Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.
作者信息
Ji Dong, Xu Jing, Qin Enqiang, Zhang Dawei, Cheng Gregory, Wang Yudong, Lau George
机构信息
The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Fuyang Second People's Hospital, Fuyang, Anhui 236000, China.
出版信息
J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6.
Abstract
摘要
相似文献
1
Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.
J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6.
2
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
3
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy.
J Hepatol. 2020 Sep;73(3):702-705. doi: 10.1016/j.jhep.2020.05.008. Epub 2020 May 12.
4
COVID 19 and the Liver.
J Assoc Physicians India. 2020 Nov;68(11):11-12.
5
COVID-19: An Overview of Worldwide Recommendations for Management of Patients With Liver Diseases or Liver Transplantation.
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2381-2384.e10. doi: 10.1016/j.cgh.2020.04.074. Epub 2020 May 12.
6
Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests".
J Hepatol. 2020 Sep;73(3):713-714. doi: 10.1016/j.jhep.2020.04.042. Epub 2020 May 6.
7
Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply.
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):799-800. doi: 10.1016/S2468-1253(20)30240-5.
8
Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
Semin Liver Dis. 2020 Aug;40(3):321-330. doi: 10.1055/s-0040-1715108. Epub 2020 Sep 4.
9
Treatments for COVID-19: emerging drugs against the coronavirus - reply.
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
10
[The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):217-221. doi: 10.3760/cma.j.cn501113-20200309-00095.
引用本文的文献
1
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.
World J Gastroenterol. 2023 Jan 21;29(3):487-502. doi: 10.3748/wjg.v29.i3.487.
2
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.
Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101807. doi: 10.1016/j.clinre.2021.101807. Epub 2021 Sep 17.
3
Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic.
World J Clin Cases. 2021 Jun 16;9(17):4133-4142. doi: 10.12998/wjcc.v9.i17.4133.
4
Maximum chest CT score is associated with progression to severe illness in patients with COVID-19: a retrospective study from Wuhan, China.
BMC Infect Dis. 2020 Dec 11;20(1):953. doi: 10.1186/s12879-020-05683-3.
5
Liver stiffness by transient elastography accompanies illness severity in COVID-19.
BMJ Open Gastroenterol. 2020 Jul;7(1). doi: 10.1136/bmjgast-2020-000445.
6
COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics.
Eur J Clin Invest. 2020 Oct;50(10):e13338. doi: 10.1111/eci.13338. Epub 2020 Aug 26.
本文引用的文献
1
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
2
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.
3
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Gastroenterology. 2020 Jul;159(1):81-95. doi: 10.1053/j.gastro.2020.03.065. Epub 2020 Apr 3.
4
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.
JHEP Rep. 2019 Feb 23;1(1):30-43. doi: 10.1016/j.jhepr.2019.02.004. eCollection 2019 May.
5
Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.
Front Immunol. 2019 May 10;10:1071. doi: 10.3389/fimmu.2019.01071. eCollection 2019.
6
Liver: An organ with predominant innate immunity.
Hepatology. 2008 Feb;47(2):729-36. doi: 10.1002/hep.22034.
Zotero 插件